Recto, Analyn .

HRN: 22-59-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/15/2023
02/22/2023
IV
500 Mg
Every 8 Hours
Thinly Meconium-Stained Amniotic Fluid
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: